<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Donohue MC</submitter><funding>ADNI</funding><funding>Alzheimer's Association; Alzheimer's Drug Discovery Foundation</funding><funding>Lumosity</funding><funding>NIBIB NIH HHS</funding><funding>Pfizer Inc.</funding><funding>NIA NIH HHS</funding><funding>Cogstate</funding><funding>IXICO Ltd.</funding><funding>Eisai Inc.</funding><funding>GE Healthcare</funding><funding>Eli Lilly and Company</funding><funding>CereSpir, Inc.</funding><funding>Fujirebio</funding><funding>Transition Therapeutics</funding><funding>Statewide California Electronic Library Consortium</funding><funding>Merck &amp; Co., Inc.</funding><funding>Novartis Pharmaceuticals Corporation</funding><funding>Epstein Family Foundation</funding><funding>Takeda Pharmaceutical Company</funding><funding>Foundation for the National Institutes of Health</funding><funding>BristolMyers Squibb Company</funding><funding>Northern California Institute for Research and Education</funding><funding>Araclon Biotech</funding><funding>Meso Scale Diagnostics, LLC.</funding><funding>Servier</funding><funding>SCELC</funding><funding>NIH HHS</funding><funding>Albert Einstein College of Medicine and the Foundation for Neurologic Diseases</funding><funding>GHR Foundation</funding><funding>Yugilbar Foundation</funding><funding>NIA</funding><funding>Elan Pharmaceuticals, Inc.</funding><funding>Neurotrack Technologies</funding><funding>AbbVie</funding><funding>BioClinica, Inc.</funding><funding>Davis Alzheimer Prevention Program</funding><funding>CIHR</funding><funding>Piramal Imaging</funding><funding>Alzheimer's Disease Neuroimaging Initiative</funding><funding>NeuroRx Research</funding><funding>Genentech, Inc.</funding><funding>Biogen</funding><funding>Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC.</funding><funding>Lundbeck</funding><funding>Avid Radiopharmaceuticals</funding><funding>Women's Hospital</funding><pagination>e71152</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12854935</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Sharing clinical research data is essential for advancing Alzheimer's disease (AD) research, yet challenges in accessibility, standardization, documentation, usability, and reproducibility persist.&lt;h4>Methods&lt;/h4>We developed R data packages to streamline access to curated datasets from key AD studies. A4LEARN includes data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) randomized trial and its companion observational study, the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN). ADNIMERGE2 contains curated data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a longitudinal biomarker and imaging study.&lt;h4>Results&lt;/h4>These packages bundle data, documentation, and reproducible analysis vignettes into portable, analysis-r</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Alzheimer's clinical research data via R packages: The alzverse.</pubmed_title><pmcid>PMC12854935</pmcid><funding_grant_id>U24AG057437</funding_grant_id><funding_grant_id>U19AG024904</funding_grant_id><pubmed_authors>Donohue MC</pubmed_authors><pubmed_authors>Gallardo R</pubmed_authors><pubmed_authors>Alzheimer's Disease Neuroimaging Initiative</pubmed_authors><pubmed_authors>Langford O</pubmed_authors><pubmed_authors>Aisen PS</pubmed_authors><pubmed_authors>Jimenez-Maggiora G</pubmed_authors><pubmed_authors>Hussen K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alzheimer's clinical research data via R packages: The alzverse.</name><description>&lt;h4>Introduction&lt;/h4>Sharing clinical research data is essential for advancing Alzheimer's disease (AD) research, yet challenges in accessibility, standardization, documentation, usability, and reproducibility persist.&lt;h4>Methods&lt;/h4>We developed R data packages to streamline access to curated datasets from key AD studies. A4LEARN includes data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) randomized trial and its companion observational study, the Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN). ADNIMERGE2 contains curated data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a longitudinal biomarker and imaging study.&lt;h4>Results&lt;/h4>These packages bundle data, documentation, and reproducible analysis vignettes into portable, analysis-r</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-06-15T08:53:30.467Z</modification><creation>2026-06-15T03:11:51.821Z</creation></dates><accession>S-EPMC12854935</accession><cross_references><pubmed>41611624</pubmed><doi>10.1002/alz.71152</doi></cross_references></HashMap>